These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 9398875

  • 1. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
    Harford W, Lanza F, Arora A, Graham D, Haber M, Weissfeld A, Rose P, Siepman N.
    Helicobacter; 1996 Dec; 1(4):243-50. PubMed ID: 9398875
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study).
    Di Mario F, Battaglia F, Dal Bò N, Leandro G, Benedetti E, Bottona E, Caroli A, Costan-Biedo F, De Bastiani R, Germanà B, Andrea Grassi S, Madia D, Marcon V, Marin R, Monica F, Olivieri P, Orzes N, Pilotto A, Ronzani G, Saggioro A, Tafner G.
    Dig Liver Dis; 2000 Mar; 32(2):108-15. PubMed ID: 10975783
    [Abstract] [Full Text] [Related]

  • 4. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer.
    O'Morain C, Dettmer A, Rambow A, von Fritsch E, Fraser AG.
    Helicobacter; 1996 Sep; 1(3):130-7. PubMed ID: 9398893
    [Abstract] [Full Text] [Related]

  • 5. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S, Flury R, Zbinden R, Fried M, Wirth HP.
    Schweiz Med Wochenschr; 1997 Apr 26; 127(17):722-7. PubMed ID: 9221483
    [Abstract] [Full Text] [Related]

  • 6. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
    Bazzoli F, Zagari RM, Pozzato P, Fossi S, Ricciardiello L, Nicolini G, De Luca L, Berretti D, Alampi G, Di Pietro C, Morelli P, Roda E.
    Aliment Pharmacol Ther; 2002 Jan 26; 16(1):153-8. PubMed ID: 11856090
    [Abstract] [Full Text] [Related]

  • 7. Cure of refractory duodenal ulcer and infection caused by Helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient.
    Furuta T, Takashima M, Shirai N, Xiao F, Hanai H, Ohashi K, Ishizaki T.
    Clin Pharmacol Ther; 2000 Jun 26; 67(6):684-9. PubMed ID: 10872651
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
    Harris AW, Misiewicz JJ, Bardhan KD, Levi S, O'Morain C, Cooper BT, Kerr GD, Dixon MF, Langworthy H, Piper D.
    Aliment Pharmacol Ther; 1998 Aug 26; 12(8):741-5. PubMed ID: 9726387
    [Abstract] [Full Text] [Related]

  • 10. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T, Shirai N, Takashima M, Xiao F, Hanai H, Sugimura H, Ohashi K, Ishizaki T, Kaneko E.
    Clin Pharmacol Ther; 2001 Mar 26; 69(3):158-68. PubMed ID: 11240980
    [Abstract] [Full Text] [Related]

  • 11. Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients.
    Kato M, Asaka M, Kudo M, Sukegawa M, Katagiri M, Koshiyama T, Kagaya H, Nishikawa K, Hokari K, Takeda H, Sugiyama T.
    Aliment Pharmacol Ther; 1996 Oct 26; 10(5):821-7. PubMed ID: 8899093
    [Abstract] [Full Text] [Related]

  • 12. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
    Wong BC, Xiao SD, Hu FL, Qian SC, Huang NX, Li YY, Hu PJ, Daldiyono, Manan C, Lesmana L, Carpio RE, Perez JY, Fock KM, Kachintorn U, Phornphutkul K, Kullavanijaya P, Ho J, Lam SK.
    Aliment Pharmacol Ther; 2000 Feb 26; 14(2):217-24. PubMed ID: 10651663
    [Abstract] [Full Text] [Related]

  • 13. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
    Sugiyama T, Hisano K, Ochiai T, Fujita N, Kobayashi T, Yabana T, Kurokawa I, Yachi A.
    J Clin Gastroenterol; 1995 Feb 26; 20 Suppl 2():S104-6. PubMed ID: 7594322
    [Abstract] [Full Text] [Related]

  • 14. Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy.
    Catalano F, Branciforte G, Catanzaro R, Bentivegna C, Cipolla R, Nuciforo G, Brogna A.
    Helicobacter; 1999 Sep 26; 4(3):178-84. PubMed ID: 10469192
    [Abstract] [Full Text] [Related]

  • 15. Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
    Maconi G, Russo A, Imbesi V, Cucino C, Bianchi Porro G.
    Dig Liver Dis; 2000 May 26; 32(4):275-80. PubMed ID: 11515622
    [Abstract] [Full Text] [Related]

  • 16. High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection.
    Malaty H, el-Zimaity HM, Genta RM, Cole RA, Graham DY.
    Aliment Pharmacol Ther; 1996 Dec 26; 10(6):1001-4. PubMed ID: 8971301
    [Abstract] [Full Text] [Related]

  • 17. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
    Misiewicz JJ, Harris AW, Bardhan KD, Levi S, O'Morain C, Cooper BT, Kerr GD, Dixon MF, Langworthy H, Piper D.
    Gut; 1997 Dec 26; 41(6):735-9. PubMed ID: 9462204
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer.
    Labenz J, Tillenburg B, Weismüller J, Lütke A, Stolte M.
    Aliment Pharmacol Ther; 1997 Feb 26; 11(1):95-100. PubMed ID: 9042979
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Omeprazole-based dual and triple therapy for the treatment of Helicobacter pylori infection in peptic ulcer disease: a randomized trial.
    Pieramico O, Zanetti MV, Innerhofer M, Malfertheiner P.
    Helicobacter; 1997 Jun 26; 2(2):92-7. PubMed ID: 9432335
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.